X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-21 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale+OE | $35.73 | -50,000 | 4,965,012 | -1% | -$1,786,700 | |||||
| D | 2023-03-17 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale+OE | $35.63 | -37,913 | 3,874,769 | -1% | -$1,350,689 | |||||
| DM | 2023-03-15 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale+OE | $35.62 | -81,689 | 4,948,039 | -2% | -$2,909,406 | |||||
2023-03-09 | OSH | Guenthner Robert | GC | S - Sale | $35.43 | -8,250 | 432,759 | -2% | -$292,281 | ||||||
| D | 2023-03-07 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale+OE | $35.54 | -50,000 | 3,817,135 | -1% | -$1,776,900 | |||||
2023-02-23 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale | $35.48 | -7,728 | 4,940,405 | 0% | -$274,227 | ||||||
2023-02-23 | OSH | Guenthner Robert | GC | S - Sale | $35.47 | -10,768 | 441,009 | -2% | -$381,929 | ||||||
2023-02-23 | OSH | Cook Timothy M | CFO | S - Sale | $35.48 | -5,107 | 1,436,616 | 0% | -$181,221 | ||||||
| DM | 2023-02-21 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale+OE | $35.52 | -172,985 | 3,874,863 | -4% | -$6,145,154 | |||||
| D | 2023-02-10 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale+OE | $35.60 | -7,413 | 4,948,133 | 0% | -$263,903 | |||||
2023-02-09 | OSH | Guenthner Robert | GC | S - Sale | $35.26 | -8,250 | 451,777 | -2% | -$290,887 | ||||||
| D | 2023-02-07 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale+OE | $34.07 | -400,000 | 4,948,133 | -7% | -$13,629,520 | |||||
2023-02-02 | OSH | Cook Timothy M | CFO | S - Sale | $28.49 | -1,480 | 1,441,723 | 0% | -$42,161 | ||||||
2023-02-02 | OSH | Guenthner Robert | GC | S - Sale | $28.85 | -592 | 460,027 | 0% | -$17,077 | ||||||
2023-01-26 | OSH | Guenthner Robert | GC | S - Sale | $28.36 | -8,250 | 460,619 | -2% | -$233,943 | ||||||
2023-01-13 | OSH | Clem Brian | COO | S - Sale | $30.15 | -20,809 | 468,816 | -4% | -$627,412 | ||||||
2023-01-12 | OSH | Clem Brian | COO | S - Sale | $30.02 | -6,601 | 489,577 | -1% | -$198,155 | ||||||
| D | 2023-01-10 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale+OE | $29.74 | -50,000 | 7,699,726 | -1% | -$1,486,835 | |||||
| M | 2023-01-10 | OSH | Clem Brian | COO | S - Sale | $29.68 | -50,159 | 496,226 | -9% | -$1,488,698 | |||||
2023-01-03 | OSH | Clem Brian | COO | S - Sale | $24.02 | -5,000 | 546,337 | -1% | -$120,085 | ||||||
2022-12-01 | OSH | Clem Brian | COO | S - Sale | $21.83 | -5,000 | 551,385 | -1% | -$109,145 | ||||||
2022-11-01 | OSH | Clem Brian | COO | S - Sale | $20.57 | -5,000 | 556,337 | -1% | -$102,855 | ||||||
| M | 2022-10-03 | OSH | Clem Brian | COO | S - Sale | $24.48 | -7,431 | 561,385 | -1% | -$181,916 | |||||
2022-09-22 | OSH | Myers Griffin | Chief Medical Officer | S - Sale | $26.32 | -50,000 | 4,854,207 | -1% | -$1,315,875 | ||||||
2022-09-16 | OSH | Newlight Partners LP | Dir, 10% | S - Sale | $24.72 | -838,496 | 32,671,144 | -3% | -$20,727,621 | ||||||
2022-09-08 | OSH | Myers Griffin | Chief Medical Officer | S - Sale | $27.39 | -50,000 | 4,904,207 | -1% | -$1,369,481 | ||||||
2022-09-06 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale | $24.90 | -40,000 | 4,948,133 | -1% | -$996,187 | ||||||
2022-09-01 | OSH | Clem Brian | COO | S - Sale | $25.39 | -10,000 | 568,816 | -2% | -$253,912 | ||||||
2022-08-25 | OSH | Myers Griffin | Chief Medical Officer | S - Sale | $28.95 | -50,000 | 4,954,207 | -1% | -$1,447,500 | ||||||
2022-08-23 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale | $25.71 | -40,000 | 4,988,133 | -1% | -$1,028,354 | ||||||
2022-08-19 | OSH | Newlight Partners LP | Dir, 10% | S - Sale | $24.72 | -7,000,000 | 33,509,640 | -17% | -$173,040,000 | ||||||
2022-08-17 | OSH | Clem Brian | COO | S - Sale | $25.75 | -10,000 | 586,468 | -2% | -$257,545 | ||||||
2022-08-11 | OSH | Myers Griffin | Chief Medical Officer | S - Sale | $29.08 | -50,000 | 5,004,207 | -1% | -$1,453,853 | ||||||
2022-08-11 | OSH | Pykosz Michael T | CEO | S - Sale | $29.32 | -15 | 8,226,133 | 0% | -$440 | ||||||
2022-08-09 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale | $29.08 | -40,000 | 5,028,133 | -1% | -$1,163,128 | ||||||
| M | 2022-08-04 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale | $30.27 | -199,889 | 5,068,133 | -4% | -$6,051,309 | |||||
2022-08-02 | OSH | Clem Brian | COO | S - Sale | $30.00 | -40,000 | 596,516 | -6% | -$1,200,000 | ||||||
| M | 2022-08-02 | OSH | Pykosz Michael T | CEO | S - Sale | $30.04 | -160,710 | 8,226,148 | -2% | -$4,827,042 | |||||
| M | 2022-08-02 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale | $30.03 | -150,111 | 5,268,022 | -3% | -$4,508,436 | |||||
2022-07-28 | OSH | Myers Griffin | Chief Medical Officer | S - Sale | $28.63 | -200,000 | 5,054,159 | -4% | -$5,726,650 | ||||||
2022-07-26 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale | $27.97 | -40,000 | 1,543,270 | -3% | -$1,118,680 | ||||||
2022-07-20 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale | $21.20 | -150,000 | 1,583,270 | -9% | -$3,179,250 | ||||||
2022-07-12 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale | $22.41 | -62,800 | 1,733,270 | -3% | -$1,407,288 | ||||||
| M | 2022-06-28 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale | $18.55 | -97,200 | 1,796,070 | -5% | -$1,803,231 | |||||
2022-05-31 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale | $18.91 | -120,000 | 1,893,270 | -6% | -$2,268,960 | ||||||
2022-05-03 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale | $18.91 | -60,000 | 2,013,270 | -3% | -$1,134,310 | ||||||
2022-04-19 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale | $24.91 | -60,000 | 5,944,647 | -1% | -$1,494,877 | ||||||
2022-04-05 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale | $26.56 | -60,000 | 6,004,647 | -1% | -$1,593,523 | ||||||
2022-03-22 | OSH | Price Geoffrey M | Chief Innovation Officer | S - Sale | $24.83 | -80,000 | 6,072,347 | -1% | -$1,986,364 | ||||||
2022-03-03 | OSH | Clem Brian | COO | S - Sale | $21.35 | -15,000 | 636,516 | -2% | -$320,318 | ||||||
2022-02-17 | OSH | Clem Brian | COO | S - Sale | $16.44 | -15,000 | 581,675 | -3% | -$246,671 | ||||||
2022-02-04 | OSH | Guenthner Robert | GC | S - Sale | $16.66 | -606 | 445,834 | 0% | -$10,093 | ||||||
2022-02-04 | OSH | Cook Timothy M | CFO | S - Sale | $16.66 | -1,514 | 1,373,362 | 0% | -$25,216 | ||||||
2022-02-04 | OSH | Clem Brian | COO | S - Sale | $16.66 | -1,151 | 596,675 | 0% | -$19,170 | ||||||
2022-01-11 | OSH | Price Geoffrey M | COO | S - Sale | $25.02 | -12,500 | 6,082,461 | 0% | -$312,775 | ||||||
2022-01-04 | OSH | Pykosz Michael T | CEO | S - Sale | $33.19 | -25,000 | 8,386,858 | 0% | -$829,810 | ||||||
2021-12-28 | OSH | Price Geoffrey M | COO | S - Sale | $34.10 | -27,500 | 6,094,961 | 0% | -$937,615 | ||||||
2021-12-16 | OSH | Guenthner Robert | GC | S - Sale | $31.46 | -2,533 | 446,440 | -1% | -$79,695 | ||||||
2021-12-14 | OSH | Price Geoffrey M | COO | S - Sale | $32.02 | -27,500 | 6,117,745 | 0% | -$880,469 | ||||||
2021-12-02 | OSH | Guenthner Robert | GC | S - Sale | $31.44 | -419 | 458,973 | 0% | -$13,173 | ||||||
2021-11-23 | OSH | Price Geoffrey M | COO | S - Sale | $31.82 | -27,500 | 6,144,807 | 0% | -$875,124 | ||||||
2021-11-18 | OSH | Guenthner Robert | GC | S - Sale | $36.76 | -1,476 | 459,392 | 0% | -$54,262 | ||||||
2021-11-16 | OSH | Myers Griffin | Chief Medical Officer | S - Sale | $40.30 | -86,017 | 5,237,311 | -2% | -$3,466,141 | ||||||
2021-11-16 | OSH | Pykosz Michael T | CEO | S - Sale | $39.76 | -50,000 | 8,407,514 | -1% | -$1,988,207 | ||||||
2021-11-15 | OSH | Myers Griffin | Chief Medical Officer | S - Sale | $40.00 | -23,383 | 5,323,328 | 0% | -$935,390 | ||||||
2021-11-09 | OSH | Price Geoffrey M | COO | S - Sale | $37.79 | -28,100 | 6,172,307 | 0% | -$1,061,775 | ||||||
2021-11-04 | OSH | Guenthner Robert | GC | S - Sale | $46.08 | -5,902 | 460,868 | -1% | -$271,987 | ||||||
2021-11-02 | OSH | Pykosz Michael T | CEO | S - Sale | $45.62 | -50,000 | 8,457,514 | -1% | -$2,281,054 | ||||||
2021-10-28 | OSH | Cook Timothy M | CFO | S - Sale | $46.65 | -15,000 | 1,374,876 | -1% | -$699,736 | ||||||
2021-10-26 | OSH | Price Geoffrey M | COO | S - Sale | $45.24 | -72,500 | 6,200,407 | -1% | -$3,279,968 | ||||||
2021-10-21 | OSH | Guenthner Robert | GC | S - Sale | $45.75 | -10,328 | 468,370 | -2% | -$472,505 | ||||||
2021-10-19 | OSH | Pykosz Michael T | CEO | S - Sale | $41.82 | -50,000 | 8,507,514 | -1% | -$2,091,058 | ||||||
2021-10-15 | OSH | Myers Griffin | Chief Medical Officer | S - Sale | $41.65 | -109,400 | 5,346,711 | -2% | -$4,556,215 | ||||||
2021-10-12 | OSH | Price Geoffrey M | COO | S - Sale | $37.24 | -27,500 | 6,272,907 | 0% | -$1,024,202 | ||||||
2021-10-07 | OSH | Guenthner Robert | GC | S - Sale | $41.48 | -1,476 | 477,098 | 0% | -$61,229 | ||||||
2021-10-05 | OSH | Pykosz Michael T | CEO | S - Sale | $41.75 | -50,000 | 8,557,514 | -1% | -$2,087,628 | ||||||
2021-09-28 | OSH | Price Geoffrey M | COO | S - Sale | $46.13 | -50,000 | 6,300,407 | -1% | -$2,306,550 | ||||||
2021-09-23 | OSH | Guenthner Robert | GC | S - Sale | $49.82 | -5,902 | 478,574 | -1% | -$294,059 | ||||||
2021-09-21 | OSH | Pykosz Michael T | CEO | S - Sale | $50.38 | -50,000 | 8,607,514 | -1% | -$2,518,822 | ||||||
2021-09-16 | OSH | Cook Timothy M | CFO | S - Sale | $52.04 | -15,000 | 1,389,876 | -1% | -$780,567 | ||||||
2021-09-15 | OSH | Myers Griffin | Chief Medical Officer | S - Sale | $52.00 | -109,400 | 5,456,111 | -2% | -$5,688,678 | ||||||
2021-09-14 | OSH | Price Geoffrey M | COO | S - Sale | $52.41 | -50,000 | 6,350,407 | -1% | -$2,620,602 | ||||||
2021-09-09 | OSH | Guenthner Robert | GC | S - Sale | $52.16 | -5,902 | 484,476 | -1% | -$307,823 | ||||||
2021-09-07 | OSH | Pykosz Michael T | CEO | S - Sale | $51.73 | -50,000 | 8,657,514 | -1% | -$2,586,271 | ||||||
2021-09-02 | OSH | Cook Timothy M | CFO | S - Sale | $48.88 | -5,434 | 1,404,876 | 0% | -$265,592 | ||||||
2021-08-31 | OSH | Pykosz Michael T | CEO | S - Sale | $46.20 | -50,000 | 8,457,514 | -1% | -$2,309,852 | ||||||
2021-08-26 | OSH | Guenthner Robert | GC | S - Sale | $47.12 | -5,902 | 490,378 | -1% | -$278,091 | ||||||
2021-08-24 | OSH | Price Geoffrey M | COO | S - Sale | $47.61 | -50,000 | 6,400,407 | -1% | -$2,380,400 | ||||||
2021-08-19 | OSH | Cook Timothy M | CFO | S - Sale | $45.40 | -9,566 | 1,410,310 | -1% | -$434,307 | ||||||
2021-08-17 | OSH | Pykosz Michael T | CEO | S - Sale | $46.69 | -50,000 | 8,757,514 | -1% | -$2,334,575 | ||||||
2021-08-16 | OSH | Myers Griffin | Chief Medical Officer | S - Sale | $48.46 | -109,400 | 5,565,511 | -2% | -$5,301,981 | ||||||
2021-08-12 | OSH | Guenthner Robert | GC | S - Sale | $50.72 | -5,902 | 496,280 | -1% | -$299,358 | ||||||
2021-08-10 | OSH | Price Geoffrey M | COO | S - Sale | $53.09 | -50,000 | 6,450,407 | -1% | -$2,654,308 | ||||||
2021-08-05 | OSH | Price Geoffrey M | COO | S - Sale | $65.12 | -7,893 | 6,500,407 | 0% | -$513,976 | ||||||
2021-08-03 | OSH | Pykosz Michael T | CEO | S - Sale | $64.02 | -50,000 | 8,807,514 | -1% | -$3,201,073 | ||||||
2021-07-29 | OSH | Guenthner Robert | GC | S - Sale | $62.88 | -5,902 | 502,182 | -1% | -$371,124 | ||||||
2021-07-22 | OSH | Cook Timothy M | CFO | S - Sale | $60.75 | -22,500 | 1,419,876 | -2% | -$1,366,933 | ||||||
2021-07-28 | OSH | Pykosz Michael T | CEO | S - Sale | $61.67 | -66,358 | 8,857,514 | -1% | -$4,092,483 | ||||||
2021-07-27 | OSH | Price Geoffrey M | COO | S - Sale | $59.98 | -50,000 | 6,508,252 | -1% | -$2,999,181 | ||||||
| M | 2021-07-22 | OSH | Pykosz Michael T | CEO | S - Sale | $61.09 | -18,642 | 8,923,872 | 0% | -$1,138,829 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |